Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
4.775
-0.085 (-1.75%)
At close: Mar 6, 2026, 4:00 PM EST
4.870
+0.095 (1.99%)
After-hours: Mar 6, 2026, 6:36 PM EST
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.02 million as of March 6, 2026. Its market cap has decreased by -32.04% in one year.
Market Cap
6.02M
Enterprise Value
-4.87M
1-Year Change
-32.04%
Ranking
Category
Stock Price
$4.78
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.02M, an increase of 21.04%. That is a compound annual growth rate of 1.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 6.01M | -14.10% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aspire Biopharma Holdings | 6.63M |
| Creative Medical Technology Holdings | 6.50M |
| XTL Biopharmaceuticals | 6.47M |
| Immuron | 6.46M |
| Aprea Therapeutics | 6.36M |
| Processa Pharmaceuticals | 6.34M |
| Revelation Biosciences | 6.06M |
| Psyence Biomedical | 5.94M |